FIELD: medicine, pharmaceutics.
SUBSTANCE: group of invention refers to medicine, and concerns the use of the peptide D-Trp-Aib for preparing a drug preparation for preventing or treating an ocular condition associated with β-amyloid (Aβ) toxicity; it also concerns a pharmaceutical composition for preventing or treating the ocular condition associated with β-amyloid (Aβ) toxicity, containing the peptide D-Trp-Aib.
EFFECT: group of invention provides vision improvement in the patients already having been suffering glaucomatous degeneration or delayed, or terminated progression of vision loss.
18 cl, 1 ex
